September 16, 2014
LAS VEGAS — Patients in Sweden with an implantable cardioverter defibrillator often have misperceptions about its function at the end of life that could influence decision-making regarding care, according to results presented at the Heart Failure Society of American Annual Scientific Meeting.
Researchers mailed the End-of-Life ICD Questionnaire, asking questions related to knowledge, experiences and attitudes regarding ICDs and end-of-life care, to 5,535 patients in Sweden with an ICD who were enrolled in the National Swedish ICD and Pacemaker Registry upon implantation. All participants had been implanted with an ICD at least 1 year before receiving the questionnaire. Patients also responded to the EuroQOL questionnaire to assess quality of life, and the Hospital Anxiety and Depression Scale to measure symptoms of anxiety and depression.